Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Change in Receivables (2020 - 2025)

Historic Change in Receivables for Volitionrx (VNRX) over the last 7 years, with Q3 2025 value amounting to $119488.0.

  • Volitionrx's Change in Receivables fell 1835.41% to $119488.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3526.0, marking a year-over-year decrease of 10171.82%. This contributed to the annual value of -$132045.0 for FY2024, which is 17782.64% down from last year.
  • According to the latest figures from Q3 2025, Volitionrx's Change in Receivables is $119488.0, which was down 1835.41% from $1767.0 recorded in Q2 2025.
  • Volitionrx's Change in Receivables' 5-year high stood at $230928.0 during Q3 2023, with a 5-year trough of -$315079.0 in Q2 2023.
  • Its 5-year average for Change in Receivables is $7948.1, with a median of $5556.0 in 2021.
  • Per our database at Business Quant, Volitionrx's Change in Receivables crashed by 578347.11% in 2021 and then surged by 780530.53% in 2023.
  • Quarter analysis of 5 years shows Volitionrx's Change in Receivables stood at -$24926.0 in 2021, then tumbled by 163.38% to -$65649.0 in 2022, then soared by 305.98% to $135225.0 in 2023, then crashed by 249.41% to -$202037.0 in 2024, then soared by 159.14% to $119488.0 in 2025.
  • Its Change in Receivables was $119488.0 in Q3 2025, compared to $1767.0 in Q2 2025 and $77256.0 in Q1 2025.